TG THERAPEUTICS, INC. (TGTX) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

$616.3M

Net Income/Loss (FY2025)

$447.2M

Total Assets (FY2025)

$1.1B

Total Equity (FY2025)

$648.0M

Cash Flows from Operating Activities (FY2025)

-$24.8M

Source: TG THERAPEUTICS, INC. 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.